Answers are grounded in this paper and cite their sources.
Narrative review reveals enhanced tissue regeneration and infection control in chronic wound models, indicating strong clinical promise for tri-modal hydrogel dressings.
Chronic wounds represent a major clinical challenge due to persistent inflammation, infection, and impaired tissue regeneration. This narrative review aims to critically evaluate recent advances in multifunctional biomaterial-based therapeutic strategies, with a focus on tri-modal systems combining exosomes, hydrogel scaffolds, and silver nanoparticles for enhanced wound healing. Relevant literature was identified through structured searches of PubMed, Scopus, and Web of Science up to January 2026 using combinations of the terms “exosomes,” “extracellular vesicles,” “hydrogel,” “silver nanoparticles,” “AgNPs,” “wound healing,” “nanocomposites,” and “biomaterials.” Primary studies were prioritized, particularly recent and mechanistically informative reports, while selected review articles and landmark publications were included to provide context. Studies not directly related to wound healing or lacking relevance to the tri-modal therapeutic framework were excluded from the core synthesis. Recent advances demonstrate that exosomes, hydrogels, and silver nanoparticles each contribute distinct therapeutic benefits to wound healing. Exosomes provide bioactive signaling molecules that regulate inflammation, angiogenesis, and tissue regeneration. Hydrogels serve as three-dimensional matrices enabling sustained, localized delivery of therapeutic agents. Silver nanoparticles offer potent antimicrobial activity. Their integration into tri-modal platforms enables complementary modulation of the wound microenvironment, effective infection control, and enhanced tissue repair. Key mechanistic interactions, material design considerations, and therapeutic outcomes from recent studies are critically discussed. However, challenges related to scalability, reproducibility, safety, and clinical translation remain significant. Importantly, the evidence discussed in this review is derived predominantly from preclinical in vitro and in vivo studies, and clinical efficacy and safety remain to be established. Tri-modal biomaterial systems represent a promising and conceptually advanced approach in regenerative medicine for chronic wound management. Although not yet clinically approved, these integrated platforms have substantial potential to improve therapeutic outcomes, contingent upon overcoming current translational and regulatory challenges.
No takes yet. Share an insight, caveat, or question.
Omar et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: